Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer
Conditions
- Pancreatic Adenocarcinoma Resectable
- Pancreatic Adenocarcinoma Locally Advanced
- Pancreatic Adenocarcinoma Metastatic
Interventions
- DRUG: Gemcitabine
- DRUG: Abraxane
Sponsor
Jean-Luc Van Laethem
Collaborators